INSUBCONTINENT EXCLUSIVE:
Glenmark Life Sciences sold shares in the price band of ? 695-720 per equity share.Glenmark Life Sciences' share sale via initial public
buyers (QIB) was subscribed 36.97 times.Glenmark Life Sciences sold shares in the price band of ? 695-720 per equity share
The company is a leading manufacturer of selected specialized active pharmaceutical ingredients (APIs) for chronic therapeutic areas such as
is offered at 25.09x its FY21 earnings, with a market cap of Rs
88,219 million.Given the company's leadership in select high-value non-commercialized APIs in chronic therapeutic areas, cost leadership,
valuations; we give this IPO a "Subscribe" rating,'' said Anand Rathi in its report.
